Cord Blood News 1.26, December 17, 2009. Click here if you are unable to see images in this e-mail.

TOP STORY

Unrestricted Somatic Stem Cells from Human Umbilical Cord Blood Grow in Serum-Free Medium as Spheres
These data suggest that umbilical cord blood-derived unrestricted somatic stem cells (USSC) growth medium ACF maintains USSCs in an undifferentiated state and supports growth in suspension. This is the first demonstration that USSCs can grow in a serum- and animal component-free medium and that USSCs can form spheres. [BMC Biotechnology]

MethoCult® Express: Request A Sample  
Enumerate total hematopoietic progenitors (CFC) in cord blood units in only 7 days with MethoCult® Express
by STEMCELL Technologies
 
 
REQUEST A SAMPLE STEMCELL Technologies Inc
 



SCIENCE NEWS

Umbilical Cord Could be New Source of Plentiful Stem Cells, say Pitt Researchers
Stem cells that could one day provide therapeutic options for muscle and bone disorders can be easily harvested from the tissue of the umbilical cord, just as the blood that goes through it provides precursor cells to treat some blood disorders, said University of Pittsburgh School of Medicine researchers.  The team will test the umbilical cord stem cells in animal models of cartilage and bone repair, as well as muscle regeneration. [University of Pittsburgh School of Medicine, Pittsburgh] 

Stem Cells from Umbilical Cord Used for Cerebral Palsy Treatment
For the first time in Singapore, stem cells from the umbilical cord have been used to treat cerebral palsy and this has shown positive results. [Mount Elizabeth Hospital, Singapore]

Aldecount_645x110_v01




CURRENT PUBLICATIONS

CCR5 Ligands Modulate CXCL12-Induced Chemotaxis, Adhesion, and Akt Phosphorylation of Human Cord Blood CD34+ Cells
CXCL12 and its receptor CXCR4 play an important role in hematopoietic stem/progenitor cell (HSPC) migration from and retention within the bone marrow. In addition to CXCR4, HSPCs express receptors for various other chemokines; which were examined in this study. [J Immunol]

Toxic Effects of Low Doses of Bisphenol-A on Human Placental Cells
Bisphenol-A (BPA) is extensively used in a broad range of products including baby bottles, food-storage containers, medical equipment, and consumer electronics. Thus the toxic effects of BPA concentrations, close to levels found in serum of pregnant women on human cytotrophoblasts, were investigated. [Toxicol Appl Pharmacol]

Infectious Complications after Unrelated Umbilical Cord Blood Transplantation in Adult Patients with Hematologic Malignancies
This retrospective study assessed infectious complications occurring in adult patients after umbilical cord blood transplantation. [Biol Blood Marrow Transplant]

Unrelated Cord Blood Transplantation in Pediatric Patients: A Report from Saudi Arabia
Until recently, Saudi Arabia did not have a national unrelated cord blood (UCB) bank. In this study, researchers report their experience in UCB transplantation in children using units procured from western cord blood banks. [Bone Marrow Transplant]

Mercury and Heavy Metal Profiles of Maternal and Umbilical Cord Red Blood Cells in a Japanese Population
Mercury and other heavy metal profiles, namely, lead, arsenic, cadmium, and selenium were investigated in maternal and umbilical cord red blood cells at parturition in a Japanese population. [Ecotoxicol Environ Saf]

Cord Blood Mesenchymal Stem Cells Propel Human Dendritic Cells to an Intermediate Maturation State and Boost Interleukin-12 Production by Mature Dendritic Cells
Researchers have identified an immature mesenchymal stem cell population in umbilical cord blood that remarkably, modulated dendritic cells in a different way. [Immunology]

Post-Transplant EBV-Related Lymphoproliferative Disorder Complicating Umbilical Cord Blood Transplantation in Patients of Adrenoleukodystrophy
Two cases in the unrelated umbilical cord blood transplantation (UCBT) setting were reported and the following new information was added to the literature: (i) EBV-related post-transplant lymphoproliferative disorder (PTLD) can be presented late in recipients of unrelated UCBT; (ii) in contrast to reported literatures that PTLD is a serious complication with unfavorable outcome, especially in monomorphic form, their cases showed that the clinical course may be relatively benign if treatment is initiated promptly. [Pediatr Blood Cancer]

bFGF Enhances the IGFs-Mediated Pluripotent and Differentiation Potentials in Multipotent Stem Cells
It has widely been reported that basic fibroblast growth factor (bFGF) promotes proliferation of human stem cells and contributes to the maintenance of their self-renewal capability through repeated replications. In contrast to embryonic stem cells, the effects of growth factors on adult stem cells are poorly understood, however, and were investigated in this paper. [Growth Factors]

Polymorphonuclear Leukocytes Isolated from Umbilical Cord Blood as a Useful Research Tool to Study Adherence to Cell Monolayers
To evaluate whether polymorphonuclear leukocytes (PMN) isolated from umbilical cord blood could be used for in vitro experiments to monitor neutrophil adherence, researchers compared the adherence to confluent endothelial and epithelial cell monolayers using PMN isolated from umbilical cord and adult peripheral blood. [J Immunol Methods]

Optimization of Isolation and Further Characterization of Umbilical Cord Blood-Derived Very Small Embryonic/Epiblast-Like Stem Cells
To preserve umbilical cord blood (UCB)-derived very small embryonic/epiblast-like stem cells (VSELs) in final umbilical cord blood preparations, the(remove 'the') researchers propose a relatively short and economical three-step isolation protocol that allows recovery of approximately 60% of the initial number of Lin-/CD45-/CD133+ UCB-VSELs present in freshly harvested UBC(use this abbreviation here) units. [Eur J Haematol]

Percutaneous Transplantation of Human Umbilical Cord Blood-Derived Multipotent Stem Cells in a Canine Model of Spinal Cord Injury
A method for percutaneous transplantation of human umbilical cord blood-derived multipotent stem cells under fluoroscopic guidance is described. [J Neurosurg Spine]

Middle-Term Expansion of Hematopoietic Cord Blood Cells with New Human Stromal Cell Line Feeder-Layers and Different Cytokine Cocktails
Stromal components and soluble factors, such as cytokines, can be useful to induce in vitro cell expansion. Hense, feeder-layers from new stromal cell lines and different exogenous cytokine cocktails induce HSC expansion in middle-term cultures were investigated. [Int J Mol Med]

EasySep_645x110_v01




INDUSTRY NEWS

Hamad Medical Corporation and Virgin Health Bank Sign Historic Memorandum of Understanding on Cord Blood Banking
Under the agreement, Virgin Health Bank will work with the Hamad Women's Hospital to provide patients with access to their high quality cord blood stem cell banking services.

CordLife Secures Strategic Presence in China
CordLife Limited announced that it has completed a Sale and Purchase Agreement with existing minority shareholders of China Stem Cell Company Limited for a 10 per cent stake.

Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets
Fenwal Inc. announced that the U.S. Food and Drug Administration has granted Fenwal approval to market InterSol® platelet additive solution.

Cord Blood America Says 2009 Debt Reduction Tops $10 Million
Cord Blood America, Inc. announced recently that it has reduced its debt by a total of $1.4 million so far in the fourth quarter of 2009 and total debt eliminated for the year now tops $10 million.




POLICY NEWS

CIRM Provides $11 Million Boost in Funding to Train Stem Cell Scientists
Two critical programs funded by the California Institute for Regenerative Medicine (CIRM), the state stem cell agency, got an $11 million increase recently when the agency's 29-member Governing Board voted to approve funding for two additional grants in the Training II program and five additional grants in the Bridges program. [California Institute for Regenerative Medicine, United States]

2009 Meeting Materials of the Blood Products Advisory Committee

Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25) (RFA-HL-10-019)

Coordination Core for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25) (RFA-HL-10-028)

Independent Scientist Award (Parent K02) (PA-10-057)

Academic Career Award (Parent K07) (PA-10-058)

Mentored Clinical Scientist Research Career Development Award (Parent K08) (PA-10-059)

Midcareer Investigator Award in Patient-Oriented Research (Parent K24) (PA-10-061)

NIH Pathway to Independence Award (Parent K99/R00) (PA-10-063)




EVENTS

2010 BMT Tandem Meetings
February 24-28, 2010
Orlando, United States

36th Annual Meeting of the European Group for Blood and Marrow Transplantation
March 21-24, 2010
Vienna, Austria

12th Biennial CBMTG Conference
April 7-10, 2010
Vancouver, Canada

16th Annual ISCT Meeting
May 23-26, 2010
Philadelphia, United States 

8th Annual International Umbilical Cord Blood Transplantation Symposium
June 3-5, 2010
San Francisco, United States

Select Bioscience's World Biobanking Summit
August 24-25, 2010
Edinburgh, Scotland

36th Annual ASHI Meeting
September 26-30, 2010
Hollywood, United States


 

JOB OPPORTUNITIES

Business Development Europe - Cell Therapy Products (PALL Corporation)

Research & Development Technologist - Human Embryonic & Induced Pluripotent Stem Cells (STEMCELL Technologies)

Research & Development Scientist - Mesenchymal Cell Biology (STEMCELL Technologies)

Quality Control Technologist - Media  (STEMCELL Technologies)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
Visit here to post your career opportunities. 


Have we missed an important article or publication in Cord Blood News? Click here to submit!

 
forwardafriendicon